Pdl Biopharma Inc (PDLI)

Cost of Revenue

$18.93M

TTM · Period ending: · USD

PDLI logo

PDLI Cost of Revenue

Latest reported$18.93M
PDLI TTM Cost of Revenue (-$3.20M → $18.93M)
High-resolution chart · PNG

PDLI cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Pdl Biopharma Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
18,927,000
33,960,000
43,669,000
53,619,000
51,635,000
48,528,000
50,704,000
48,460,000
54,921,000
48,560,000
38,551,000
30,537,000
16,697,000
11,132,000
6,617,000
4,065,000
0
0
0
0
0
0
0
11,931,000
17,568,000
17,568,000
17,568,000
5,637,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,801,000
35,350,000
60,348,000
84,766,000
85,398,000
88,331,000
86,292,000
78,650,000
83,426,000
82,079,000
60,257,000
43,481,000
21,272,000
1,137,000
0
0
0
0
0
0
0
0
0
0
0
0
0
-1,302,000
-2,264,000
-3,347,000
-4,198,000
-3,696,000
-3,634,000
-3,451,000
-3,500,000
-3,800,000
-3,800,000
-3,800,000
-3,700,000
-3,400,000
-3,300,000
-3,200,000
-3,200,000
-3,200,000
-3,200,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.